Empowering appropriate antimicrobial use with rapid diagnostics.

OUR MISSION

The misuse of antibiotics has created a huge global health crisis. The Test Target Treat™ initiative from Alere empowers healthcare professionals to make targeted treatment decisions sooner with rapid diagnostics - reducing inappropriate antimicrobial use and the spread of resistance.

1.0_TTT_dividerbar_440

LATEST NEWS

Executive Order Combating Antibiotic-Resistant Bacteria

Alere Applauds President Obama’s Executive Order Combating Antibiotic-Resistant Bacteria

As the global leader in rapid diagnostics for infectious disease, we commend the President for establishing a national strategy… Read More

World Health Organization (WHO) Global Report on Antibiotic Resistance

World Health Organization (WHO) Global Report on Antibiotic Resistance

The report reveals that this serious threat is no longer a prediction for the future; it is happening right now in every region of the world… Read More

Do health plans have a role in limiting antibiotic resistance?

Do health plans have a role in limiting antibiotic resistance?

The CDC calls antibiotic resistance the world’s most pressing public health threat… Read More

Molecular Flu Results in less than  15 Minutes

Molecular Flu Results in less than
15 Minutes

Alere™ i Influenza A & B is the first and only molecular test to detect and differentiate influenza A and B virus in less than 15 minutes on the user-friendly Alere™ i platform.… Read More

RAPID DIAGNOSTIC TESTING

A comprehensive set of diagnotic information, empowering a shift  in prescribing behavior away from the over-use of antibiotics.

1.0_TTT_dividerbar_440
Contact

DO YOU HAVE QUESTIONS?

Contact us today to find out more about the Test Target Treat™ initiative and how rapid diagnostics will benefit your patients.